Artemis Medicare Services Ltd vs Pramodini Medicare Ltd Stock Comparison
Artemis Medicare Services Ltd vs Pramodini Medicare Ltd Stock Comparison
Last Updated on: Oct 25, 2026
Key Highlights
The Latest Trading Price of Artemis Medicare Services Ltd is ₹ 286.1 as of 23 Oct 15:30
. The P/E Ratio of Artemis Medicare Services Ltd changed from 45.3 on March 2021 to 31.3 on March 2026 . This represents a CAGR of -5.98% over 6 yearsThe P/E Ratio of Pramodini Medicare Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Artemis Medicare Services Ltd changed from ₹ 293.88 crore on March 2021 to ₹ 3249 crore on March 2026 . This represents a CAGR of 49.26% over 6 yearsThe Market Cap of Pramodini Medicare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Artemis Medicare Services Ltd for the Jun '26 is ₹ 292.7 crore as compare to the Mar '26 revenue of ₹ 287.01 crore. This represent the growth of 1.98% The revenue of Pramodini Medicare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Artemis Medicare Services Ltd for the Jun '26 is ₹ 61.82 crore as compare to the Mar '26 ebitda of ₹ 59.38 crore. This represent the growth of 4.11% The ebitda of Pramodini Medicare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Artemis Medicare Services Ltd changed from ₹ 16.52 crore to ₹ 31.44 crore over 9 quarters. This represents a CAGR of 33.11%
The net profit of Pramodini Medicare Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0%
The Dividend Payout of Artemis Medicare Services Ltd changed from 15.2 % on March 2023 to 6.89 % on March 2026 . This represents a CAGR of -17.95% over 4 yearsThe Dividend Payout of Pramodini Medicare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .
About Artemis Medicare Services Ltd
Artemis Medicare Services Limited was incorporated on May 18, 2004.
It commenced the commercial operation by setting up Artemis Hospital (formerly Artemis Health Institute) at Gurugram on July 16, 2007.
The Company is the holding Company of Artemis Cardiac Care Private Limited and a Subsidiary of Constructive Finance Private Limited.
At present, the Company is engaged in managing and operating of multi specialty hospitals.
Artemis Health Institute is a healthcare venture launched by the Promoters of the Apollo Tyres Group.
Designed as one of the most advanced in India, the Company provide expertise in the spectrum of advanced medical & surgical interventions, comprehensive mix of inpatient and outpatient services.
The Company commenced commercial operation by setting up Artemis Hospital (formerly Artemis Health Institute) at Gurugram on July 16, 2007.
About Pramodini Medicare Ltd
Pramodini Medicare Limited was originally incorporated on September 12, 2000 as 'Pramodini Medicare Private Limited' with the Registrar of Companies, Andhra Pradesh.
Thereafter, the status of the Company changed to public limited Company and the name was changed to 'Pramodini Medicare Limited' vide fresh certificate of incorporation dated November 12, 2025.
Company was originally incorporated in the year 2000 with the objective to provide diagnostic services.
The Company provide a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India.
Diagnostic services include a comprehensive range of offerings: (i) 'Radiology' which covers Magnetic Resonance Imaging (MRI), Computed Tomography (CT scan), X- ray, Ultrasound with colour doppler, Mammography, DEXA Scan and Intervention Radiology, (ii) 'Clinical Laboratory' which includes Haematology, Micro-Biology, Immunology, Pathology & Bio-Chemistry and (iii) 'Nuclear Medicine' which includes PET-CT (Positron Emission Tomography-Computed Tomography), SPECT (Single Photon Emission Computed Tomography) and Nuclear therapy.
FAQs for the comparison of Artemis Medicare Services Ltd and null
Which company has a larger market capitalization, Artemis Medicare Services Ltd or Pramodini Medicare Ltd?
Market cap of Artemis Medicare Services Ltd is 4,529 Cr while Market cap of Pramodini Medicare Ltd is 239 Cr
What are the key factors driving the stock performance of Artemis Medicare Services Ltd and Pramodini Medicare Ltd?
The stock performance of Artemis Medicare Services Ltd and Pramodini Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Artemis Medicare Services Ltd and Pramodini Medicare Ltd?
As of October 25, 2026, the Artemis Medicare Services Ltd stock price is INR ₹286.1. On the other hand, Pramodini Medicare Ltd stock price is INR ₹108.65.
How do dividend payouts of Artemis Medicare Services Ltd and Pramodini Medicare Ltd compare?
To compare the dividend payouts of Artemis Medicare Services Ltd and Pramodini Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.